Ciclopirox (CAS 29342-05-0)

Ciclopirox, a synthetic antifungal agent, has been extensively researched for its broad-spectrum antimicrobial properties and potential applications in various scientific fields. Its mechanism of action primarily involves interfering with the function of fungal enzymes, particularly those involved in ergosterol biosynthesis, a crucial component of fungal cell membranes. Ciclopirox inhibits the activity of fungal cytochrome P450-dependent enzymes, specifically CYP51, leading to disruption of ergosterol synthesis and accumulation of toxic sterol intermediates within fungal cells. Consequently, this disrupts membrane integrity, impairs membrane fluidity, and ultimately leads to fungal cell death. In research, ciclopirox has been investigated for its efficacy against a wide range of fungal pathogens, including dermatophytes, yeasts, and molds. Additionally, its potential as an antiparasitic agent against protozoan parasites has been explored. Furthermore, studies have focused on elucidating the molecular mechanisms underlying ciclopirox resistance in fungal species, aiming to develop strategies to overcome resistance and improve outcomes. Overall, ciclopirox remains a valuable tool in microbial research for studying fungal biology, pathogenesis, and antimicrobial resistance mechanisms.